AEROSURF Phase 2b Clinical Trial on Premature Infants with Respiratory Distress Syndrome
News
Discovery Laboratories recently announced the beginning of its Phase 2b clinical trial for AEROSURF in premature babies of gestational age 26 to 32 weeks who receive noninvasive continuous positive aerosol nasal airway pressure (nCPAP) ... Read more